Clinical Trials

There are a couple I found interesting. But who knows what the results will be.

The one that interests me the most is Leronlimab. It is an experimental HIV drug that has been used to successfully treat COVID-19 patients. It has been approved to enter its second phase of testing by the FDA. The developer of the drug thinks that it could potentially be approved for use in four weeks. It has been used to treat a handful of severely ill patients in New York City hospitals; a couple were able to be removed from their ventilators.

INO-4800 was developed by Inovio Pharmaceuticals, which has received funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.It has been approved by the FDA and will start trials this week.

And then there is the drug that began the country's first clinical trial in March - Moderna, a Massachusetts biotech. It has received a grant from NIH. The biotech said it expects to have early safety data by late summer and aims to produce 1 million doses by the end of 2020.